A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
David H. Miller, Omar Khan, William Sheremata, Lance D. Blumhardt, George P. Rice, Michele Libonati, A. Willmer–Hulme, Catherine M. Dalton, Katherine Miszkiel, Paul O’Connor
New England Journal of Medicine, 2003
Abstract
This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).